FindTrial
Sign In

Clinical observation of esketamine in the treatment of perioperative depression during cardiac surgery

Clinical observation of esketamine in the treatment of perioperative depression during cardiac surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075254
Enrollment
Unknown
Registered
2023-08-30
Start date
2023-08-30
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative depression

Interventions

Experimental group:Safe dose of esketamine
Control group:Blank controls that were not given esketamine

Sponsors

Beijing Anzhen Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Perform elective heart surgery Age 18 years or older ASA grade I to III Complete medical records Can cooperate to complete the questionnaire

Exclusion criteria

Exclusion criteria: History of severe neurological disorders, including stroke, Parkinson's disease, and Alzheimer's disease History of mental disorders and related drug use Do not cooperate or refuse to complete the scale test under any circumstances Serious adverse reactions such as cardiac arrest occurred during operation Emergency surgical patient

Design outcomes

Primary

MeasureTime frame
Incidence of moderate to severe depression;Remission rates of antidepressant treatment with esketamine;—

Secondary

MeasureTime frame
VAS pain scale score;ARCI scale score;—

Countries

China

Contacts

Public ContactDuomao Lin

Beijing Anzhen Hospital, Capital Medical University

13811495413@163.com+86 138 1149 5413

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026